Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Over the 70-day study period, eligible patients visited the study clinic every 2 weeks (total
of 6 visits) and received a 28-day course of aztreonam for inhalation solution (AZLI). The
Quality of Life-Bronchiectasis (QOL-B) questionnaire was completed at several time points
during the study, in additional to pulmonary function testing and other standard procedures.